Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

Mineral Resource Estimate Confirms Pitfield's World Dominant Titanium Discovery Empire Metals Ltd., the AIM-quoted and OTCQX-traded exploration and development company, is pleased to report a maiden ...